Today's Trend
MarketAxess Holdings Inc. (NASDAQ:MKTX) is facing a mildly negative news backdrop, with analysts trimming several future earnings forecasts. The reductions suggest expectations for slower profit growth, although the stock’s valuation and recent performance may limit the immediate impact.
- Zacks Research raised its Q1 2027 earnings forecast to $2.31 per share from $2.27, indicating some confidence in near-term earnings performance.
- Keefe, Bruyette & Woods reiterated a “Market Perform” rating, while the broader analyst consensus remains around “Hold.” This suggests limited expectations for significant near-term outperformance. Keefe, Bruyette & Woods Reiterates Market Perform Rating for MarketAxess
- A separate report highlighted questions about whether MarketAxess and CBIZ transactions provide fair value for shareholders. The report is investor commentary rather than a formal change to MarketAxess’s operations or financial outlook. Are MKTX and CBZ Obtaining Fair Deals for their Shareholders?
- Zacks Research lowered its FY2026 EPS estimate to $7.98 from $8.01 and cut forecasts for Q3 and Q4 2026 to $1.94 and $1.84, respectively. The firm also reduced FY2027 EPS to $8.56 from $8.70 and trimmed estimates for multiple 2027 quarters.
- The largest revision was to FY2028 EPS, now estimated at $8.98 versus $9.49 previously. Q1 2028 and Q2 2028 forecasts were also reduced, reinforcing concerns about longer-term earnings momentum. The current-year consensus remains $8.05 per share.
- Brodsky & Smith announced an investigation involving MarketAxess, adding potential legal and governance uncertainty. Such notices do not establish wrongdoing, but they can weigh on investor sentiment and raise concerns about shareholder value. Brodsky & Smith Shareholder Update
Overall, the downward estimate revisions and investigation appear more influential than the isolated upward forecast, creating a modestly bearish catalyst for MKTX.